This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Tetsuya Oda: Innovator in Immunology
Introduction
Tetsuya Oda is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of immunology, particularly in the development of antibodies for medical applications. His work is recognized for its potential impact on diagnosing and treating infections caused by acid-fast bacilli.
Latest Patents
Tetsuya Oda holds a patent for an "Anti-lipoarabinomannan antibody and immunoassay for acid-fast bacillary infection using the antibody." This invention provides a monoclonal antibody that specifically binds to acid-fast bacillary lipoarabinomannan, with a focus on tubercle bacillary lipoarabinomannan. This advancement is crucial for improving diagnostic methods for infections such as tuberculosis.
Career Highlights
Oda is associated with Otsuka Pharmaceutical Company, Limited, where he has been instrumental in research and development efforts. His innovative approach has led to breakthroughs in the understanding and treatment of infectious diseases. His dedication to advancing medical science is evident in his work and contributions to the pharmaceutical industry.
Collaborations
Tetsuya Oda has collaborated with notable colleagues, including Kiyonori Katsuragi and Masataka Togashi. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of immunology.
Conclusion
Tetsuya Oda's contributions to immunology through his patented inventions and collaborations highlight his role as a key innovator in the medical field. His work continues to pave the way for advancements in the diagnosis and treatment of infectious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
